测量门诊红细胞输注对居家功能状态的影响:一项先导性随机对照试验的研究方案
该先导性随机交叉试验计划在三级医疗中心门诊输液中心纳入患者,随机分为按计划接受红细胞输注或不输注,经洗脱期后交叉,研究周期28天。通过佩戴加速度计监测仪连续记录日常能量消耗和步数等指标,主要结局为每日能量消耗,并每周电话访谈收集功能状态与健康结局,旨在评估加速度计监测仪用于直接评估红细胞输注对居家功能状态影响的可行性和效用。
要点
- 门诊红细胞输注对居家功能状态的影响尚不明确,能否用可穿戴设备客观量化亦不清楚。
- 该先导性随机交叉试验研究周期28天,患者自身对照,主要结局为每日能量消耗。
- 次要结局包括每日久坐时间和PROMIS Global 10问卷评分,结果将用于设计未来更确证性试验。
核心结论
- 该试验将提供关于使用加速度计监测仪直接评估红细胞输注对患者功能状态影响的可行性和效用的重要信息,其结果将用于指导未来评估门诊红细胞输注对目标人群影响的更确证性试验的价值和方法。
研究设计与样本
- 这是一项先导性随机交叉临床试验,参与者研究周期为28天,交叉设计允许每位患者作为自身对照。
- 在三级医疗中心门诊输液中心就诊的患者被随机分为按计划接受红细胞输注(输注组)或不接受计划输注(不输注组),经过适当的洗脱期后,参与者从输注组交叉到不输注组或反之。
- 研究全程使用加速度计监测仪连续记录活动水平,并通过每周电话访谈收集功能状态和健康结局。
主要发现
- 主要结局指标为每日能量消耗。
- 还将评估步数变化等表现指标。
- 其他次要结局指标包括每日久坐时间和患者报告结局测量信息系统(PROMIS)Global 10调查评分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Red blood cell (RBC) transfusion is frequently employed in both ambulatory and hospital environments with the aim of improving patient functional status. In the ambulatory setting, this practice is particularly common in patients with malignancy due to anemia associated with their cancer therapy. Increasingly, the efficacy of this US$10.5 billion per year practice has been called into question. While it is often standard of care for patients with chemotherapy-induced anemia to receive ambulatory RBC transfusions, it is unclear to what extent such transfusions affect home functional status. It is also unclear whether or not changes in functional status in this population can be objectively quantified using wearable activity monitors. We propose to directly measure the impact of outpatient RBC transfusions on at-home functional status by recording several physiological parameters and quantifiable physical activity metrics, e.g., daily energy expenditure and daily total step count, using the ActiGraph wGT3X-BT. This device is an accelerometer-based wearable activity monitor similar in size to a small watch and is worn at the waist. Study participants will wear the device during the course of their daily activities giving us quantifiable insight into activity levels in the home environment. METHODS/DESIGN: This will be a randomized crossover pilot clinical trial with a participant study duration of 28 days. The crossover nature allows each patient to serve as their own control. Briefly, patients presenting at a tertiary medical center's Ambulatory Infusion Center (AIC) will be randomized to either: (1) receive an RBC transfusion as scheduled (transfusion) or (2) abstain from the scheduled transfusion (no transfusion). After an appropriate washout period, participants will crossover from the transfusion arm to the no-transfusion arm or vice versa. Activity levels will be recorded continuously throughout the study using an accelerometry monitor. In addition to device data, functional status and health outcomes will be collected via a weekly telephone interview. The primary outcome measure will be daily energy expenditure. Performance metrics, such as step count changes, will also be evaluated. Additional secondary outcome measures will include daily sedentary time and Patient-reported Outcomes Measurement Information System (PROMIS) Global 10 Survey scores. DISCUSSION: This trial will provide important information on the feasibility and utility of using accelerometry monitors to directly assess the impact of RBC transfusion on patients' functional status. The results of the study will inform the merit and methods of a more definitive future trial evaluating the impact of ambulatory RBC transfusions in the target population. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT02835937 . Registered on 15 July 2016.
引用
- Murphree DH, Kinard TN, Khera N, et al. Measuring the impact of ambulatory red blood cell transfusion on home functional status: study protocol for a pilot randomized controlled trial. Trials. 2017. PMID: 28359342. doi:10.1186/s13063-017-1873-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。